| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Hematopathology Section, Laboratory of Anatomic Pathology,* and the Department of Hematology, Hospital Clínic, University of Barcelona, Barcelona, Spain; the Department of Cellular Biology, Physiology, and Immunology, Institute of Biotechnology and Biomedicine, Autonomous University of Barcelona, Barcelona, Spain; the Information and Studies Service, Department of Health and Social Security, Barcelona, Spain; the Department of Pathology,¶ Hospital del Mar, Barcelona, Spain; and the Department of Internal Medicine III,|| University of Ulm, Ulm, Germany
Chromosomal imbalances were examined by comparative genomic hybridization in 30 cases of B-cell chronic lymphocytic leukemia (CLL) at diagnosis, in sequential samples from 17 of these patients, and in 6 large B-cell lymphomas transformed from CLL [Richter’s syndrome (RS)] with no available previous sample. The most common imbalances in CLL at diagnosis were gains in chromosome 12 (30%), and losses in chromosomes 13 (17%), 17p (17%), 8p (7%), 11q (7%), and 14q (7%). The analysis of sequential samples showed an increased number of chromosomal imbalances in 6 of 10 (60%) patients with clinical progression and in 2 patients with stable stage C disease. No karyotypic evolution was observed in four cases with stable stage A disease and in one RS clonally unrelated to the previous CLL. Gains of 2pter, and 7pter, and losses of 8p, 11q, and 17p were recurrent alterations associated with karyotype progression. RS showed a higher number of gains, losses, total alterations, and losses of 8p and chromosome 9 than CLL at diagnosis. 17p losses were associated with p53 gene mutations and with a significantly higher number of chromosomal imbalances than tumors with normal chromosome 17 profile. However, no relationship was observed between 9p deletions and p16INK4a gene alterations. Losses of 17p and an increased number of losses at diagnosis were significantly associated with a shorter survival. These findings indicate that CLL has frequent chromosomal imbalances, which may increase during the progression of the disease and transformation into large cell lymphoma. Genetic alterations detected by comparative genomic hybridization may also be of prognostic significance.
This article has been cited by other articles:
 |
|
 |
|
  V. Fernandez, P. Jares, I. Salaverria, E. Gine, S. Bea, M. Aymerich, D. Colomer, N. Villamor, F. Bosch, E. Montserrat, et al. Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia Haematologica, January 1, 2008; 93(1): 132 - 136. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Salaverria, A. Zettl, S. Bea, V. Moreno, J. Valls, E. Hartmann, G. Ott, G. Wright, A. Lopez-Guillermo, W. C. Chan, et al. Specific Secondary Genetic Alterations in Mantle Cell Lymphoma Provide Prognostic Information Independent of the Gene Expression-Based Proliferation Signature J. Clin. Oncol., April 1, 2007; 25(10): 1216 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pfeifer, M. Pantic, I. Skatulla, J. Rawluk, C. Kreutz, U. M. Martens, P. Fisch, J. Timmer, and H. Veelken Genome-wide analysis of DNA copy number changes and LOH in CLL using high-density SNP arrays Blood, February 1, 2007; 109(3): 1202 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Austen, J. E. Powell, A. Alvi, I. Edwards, L. Hooper, J. Starczynski, A. M. R. Taylor, C. Fegan, P. Moss, and T. Stankovic Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL Blood, November 1, 2005; 106(9): 3175 - 3182. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Rubio-Moscardo, D. Blesa, C. Mestre, R. Siebert, T. Balasas, A. Benito, A. Rosenwald, J. Climent, J. I. Martinez, M. Schilhabel, et al. Characterization of 8p21.3 chromosomal deletions in B-cell lymphoma: TRAIL-R1 and TRAIL-R2 as candidate dosage-dependent tumor suppressor genes Blood, November 1, 2005; 106(9): 3214 - 3222. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Iranzo, I. Lopez, M. T. Robles, J. M. Mascaro Jr, E. Campo, and C. Herrero Bullous Pemphigoid Associated With Mantle Cell Lymphoma Arch Dermatol, December 1, 2004; 140(12): 1496 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bea, L. Colomo, A. Lopez-Guillermo, I. Salaverria, X. Puig, M. Pinyol, S. Rives, E. Montserrat, and E. Campo Clinicopathologic Significance and Prognostic Value of Chromosomal Imbalances in Diffuse Large B-Cell Lymphomas J. Clin. Oncol., September 1, 2004; 22(17): 3498 - 3506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Wilkens, P. Flemming, M. Gebel, J. Bleck, C. Terkamp, L. Wingen, H. Kreipe, and B. Schlegelberger Induction of aneuploidy by increasing chromosomal instability during dedifferentiation of hepatocellular carcinoma PNAS, February 3, 2004; 101(5): 1309 - 1314. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Schwaenen, M. Nessling, S. Wessendorf, T. Salvi, G. Wrobel, B. Radlwimmer, H. A. Kestler, C. Haslinger, S. Stilgenbauer, H. Dohner, et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: Development of a clinical tool and discovery of recurrent genomic alterations PNAS, January 27, 2004; 101(4): 1039 - 1044. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Franco, A. M. Florena, and E. Iannitto Splenic marginal zone lymphoma Blood, April 1, 2003; 101(7): 2464 - 2472. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
